Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Pediatric-inspired therapy and blinatumomab consolidation improve outcomes in young adults with Philadelphia-like acute lymphoblastic leukemia.
Journal: Haematologica
Published: June 24, 2026
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.
Journal: American journal of hematology
Published: May 29, 2026
Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: May 01, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: January 30, 2026
Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT.
Journal: Blood neoplasia
Published: December 19, 2025
Extramedullary sites of disease in B-cell acute lymphoblastic leukemia: incidence, biology, and treatment.
Journal: Leukemia & lymphoma
Published: August 05, 2025
Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid Leukemia.
Journal: Transplantation and cellular therapy
Published: July 28, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.
Journal: American journal of hematology
Published: June 21, 2025
Comparison of CALGB 10403 and HyperCVAD in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia in adults ≥40 years old.
Journal: Leukemia & lymphoma
Published: May 21, 2025
The Role of Transplant for Philadelphia-positive B-cell Acute Lymphoblastic Leukemia in 2025.
Journal: Current oncology reports
Published: April 25, 2025
Last Updated: 09/26/2026